Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCroma Security Regulatory News (CSSG)

Share Price Information for Croma Security (CSSG)

Share Price is delayed by 15 minutes
Get Live Data
67.50    0.00 (0.00%)
Bid:
65.00
Ask:
70.00
Spread: 5.00 (7.692%)
Market Cap: £9.29m
CSSG Live PriceLast checked at - London Stock Exchange

Intraday Croma Security Share Chart

Issue of Equity

16 Nov 2009 18:18

RNS Number : 5997C
Croma Group PLC
16 November 2009
 



Croma Group PLC

Issue of equity and directors' dealings 

The Board of Croma Group PLC ("Croma" or the "Company") announces that, on 16 November 2009, it issued and allotted 6,500,000 new ordinary shares of 0.1 pence each ("New Ordinary Shares") (representing approximately 3.66 per cent. of the current issued share capital of the Company) at a price of 2.0 pence per share (the "Subscription Price"), to directors raising £130,000 (before expenses) pursuant to a subscription. The net subscription proceeds will be used for the repayment of debt. 

The New Ordinary Shares are being subscribed for under existing authorities to issue and allot shares. 

Application has been made to the London Stock Exchange for the 6,500,000 New Ordinary Shares to be admitted to trading on AIM and it is expected that dealings will commence on or around 20 November 2009. 

Directors' dealings 

Pursuant to the subscription, Sebastian Morley, a director of the Company, has subscribed for 2,500,000 New Ordinary Shares at the Subscription Price. Following this transaction, Sebastian Morley's beneficial interest in the Company is 21,028,634 ordinary shares, representing approximately 11.44 per cent. of the enlarged issued share capital of the Company. 

Gerald McGill, a director of the Company, has subscribed for 500,000 New Ordinary Shares at the Subscription Price pursuant to the subscription. Following this transaction, Gerald McGill's beneficial interest in the Company is 1,250,000 ordinary shares, representing approximately 0.68 per cent. of the enlarged issued share capital of the Company. 

James Sullivan, a director of the Company, has subscribed for 1,000,000 New Ordinary Shares at the Subscription Price pursuant to the subscription. Following this transaction, James Sullivan's beneficial interest in the Company is 1,000,000 ordinary shares, representing approximately 0.54 per cent. of the enlarged issued share capital of the Company. 

Furthermore, Nicholas Hewson, a director of the Company, has subscribed for 2,500,000 New Ordinary Shares at the Subscription Price pursuant to the subscription. Following this transaction, Nicholas Hewson's beneficial interest in the Company is 6,354,342 ordinary shares, representing approximately 3.46 per cent. of the enlarged issued share capital of the Company. 

Total Voting Rights

In accordance with FSA's Disclosure and Transparency Rules, the Company advises that its increased issued share capital comprises 183,883,964 ordinary shares of 0.1 pence each. The voting rights of all of these shares are identical with each share carrying the right to one vote. The Company holds no ordinary shares in Treasury. The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Croma Group Plc under the Disclosure and Transparency Rules.

For further information contact:

Croma Group PLC:

Sebastian Morley, CEO

Tel: 07768 006909

Brewin Dolphin:

Sandy Fraser, Managing Director - Corporate Finance (NOMAD)

Tel: 0845 213 2072

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEBFBPTMMBBBPL
Date   Source Headline
1st Mar 20127:00 amRNSReverse Acquisition and Placing
1st Mar 20127:00 amRNSInterim Results
9th Feb 20127:00 amRNSContract Win
1st Feb 20127:00 amRNSAppointment of Nominated Adviser and Broker
16th Dec 201112:07 pmRNSResult of AGM
23rd Nov 20117:00 amRNSResults for the Year to 30 June 2011
30th Sep 20117:00 amRNSStatement re Annual Results
4th Aug 20117:00 amRNSTrading Update
1st Aug 20117:00 amRNSContract Wins
5th Jul 20117:00 amRNSNew Contract Win
19th May 201111:05 amRNSNew Contract Win
19th Apr 20112:45 pmRNSDirectorate Change
4th Apr 201110:05 amRNSDirector/PDMR Shareholding
31st Mar 20112:16 pmRNSHalf Yearly Report
31st Mar 20112:15 pmRNSDisposal
22nd Mar 20117:00 amRNSContract Wins
24th Feb 201111:18 amRNSHolding(s) in Company
19th Jan 20117:00 amRNSResignation of Director
30th Dec 20102:47 pmRNSResult of AGM
30th Nov 20102:09 pmRNSAnnual Report and Accounts
29th Nov 20107:00 amRNSFinal Results for the Year to 30th June 2010
28th Jul 20109:55 amRNSDiscussions for Sale of Avionics Subsidiary
16th Jun 20103:36 pmRNSDirector/PDMR Shareholding
15th Jun 20102:08 pmRNSHolding(s) in Company
14th Jun 20109:57 amRNSHolding(s) in Company
11th Jun 20109:51 amRNSIssue of Equity
11th May 20109:31 amRNSDirector/PDMR Shareholding
29th Apr 20104:10 pmRNSDirector/PDMR Shareholding
29th Apr 201012:16 pmRNSHolding(s) in Company
26th Apr 201011:33 amRNSDirector/PDMR Shareholding
31st Mar 20101:39 pmRNSDirector/PDMR Shareholding
22nd Mar 20107:00 amRNSHalf Yearly Report
16th Mar 20103:23 pmRNSRe Contract
9th Dec 20098:34 amRNSIssue of equity and director shareholding
8th Dec 20094:13 pmRNSAnnual General Meeting
20th Nov 20094:53 pmRNSHolding(s) in Company
16th Nov 20096:18 pmRNSIssue of Equity
13th Nov 20095:47 pmRNSHolding(s) in Company
12th Nov 20097:00 amRNSRe Contract
10th Nov 20097:00 amRNSPublication of 2009 Annual Report and Accounts
9th Nov 20097:02 amRNSChange of NOMAD and Broker
9th Nov 20097:00 amRNSFinal Results for the year to 30 June 2009
8th Jul 20093:24 pmRNSShare Capital&Premium account reductions approved
26th May 20094:58 pmRNSResult of EGM and Class Meeting
1st May 20092:58 pmRNSNotice of EGM
30th Apr 200910:56 amRNSDirector/PDMR Shareholding
20th Apr 20099:21 amRNSDirector/PDMR Shareholding
27th Mar 20097:00 amRNSInterim Results
23rd Feb 200910:49 amRNSHolding(s) in Company
13th Feb 20099:28 amRNSRe Contract

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.